Clinical trial
Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia
NCT05016921 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transcutaneous Magnetic Stimulation of the Stellate Ganglion to Treat Ventricular Tachycardia
- Lead sponsor
- University of Pennsylvania
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- January 1, 2024
- Completion date
- January 1, 2024
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ventricular tachycardia